Baker L R, Barnett M D, Brozovic B, Cattell W R, Ackrill P, McAlister J, Nimmon C
Clin Nephrol. 1976 Jul;6(1):326-8.
Hemosiderosis following regular administration of parenteral iron was observed in a patient receiving maintenance hemodialysis. Infusions of desferrioxamine in doses of 2,3 and 4 g each resulted in the removal of approximately 45 mg of iron during dialysis. Desferrioxamine 2 g was infused thrice weekly during dialysis for twelve months. Body iron stores, as judged by liver iron and serum ferritin concentrations, fell by about half. This agrees well with the result calculated from the amount of iron administered and the amount removed during dialysis.
在一名接受维持性血液透析的患者中观察到,长期胃肠外给予铁剂后出现了含铁血黄素沉着症。每次分别输注2克、3克和4克去铁胺,在透析期间可清除约45毫克铁。在透析期间每周三次输注2克去铁胺,持续十二个月。根据肝脏铁含量和血清铁蛋白浓度判断,体内铁储备下降了约一半。这与根据给药量和透析期间清除量计算得出的结果非常吻合。